“2026 Fiscal Year Medical Fee Revision and Hospital Management” Seminar by Professor Katsuhiro Kimura of Takasaki University of Health and Welfare to be Held on Tuesday, March 17, 2026! | Press Release from Shin Shakai Systems Research Institute Co., Ltd. – PR TIMES

News Highlights

Shin Shakai Systems Research Institute will host a seminar on March 17, 2026, inviting Professor Katsuhiro Kimura of Takasaki University of Health and Welfare, on the theme of “2026 Fiscal Year Medical Fee Revision and Hospital Management.” This seminar will provide an opportunity to discuss strategies that hospital managers should adopt in anticipation of the upcoming medical fee revision, and the nature of business succession that accompanies it. In particular, points leading to M&A and business succession, such as preparation for the revision, economies of scale, and utilization of tax schemes, are suggested.

M&A Medical Editorial Department’s Perspective

The 2026 fiscal year medical fee revision will directly impact the management strategies of medical institutions. The seminar featuring Professor Kimura is an excellent opportunity to concretely consider preparations for this revision. In particular, in anticipation of changes in the revenue structure due to the revision, grouping to enjoy economies of scale and utilizing tax benefits by transitioning to specific medical corporations or social medical corporations can be options for fundamental management restructuring, not just cost reduction. For example, considering concrete M&A schemes, such as the integration of multiple hospitals within a region or the development of new services through collaboration with different industries, will be key to overcoming this revision. It is essential to incorporate this into a business succession plan with a medium-to-long-term perspective, rather than a single-year measure.

Points Highlighted by This News

• Early response to the 2026 fiscal year medical fee revision may determine the success or failure of hospital management.
• Leveraging economies of scale through grouping and distributing the burden of capital investment contributes to management stabilization.
• Consideration of tax schemes with a view to transitioning to specific medical corporations or social medical corporations is important.
• An integrated review of medium-to-long-term management strategies and business succession strategies, triggered by the medical fee revision, is required.

Practical Questions Arising from This News

• Which medical departments or services are particularly vulnerable to the impact of the 2026 fiscal year medical fee revision?
• What specific conditions and scale are necessary to concretely benefit from economies of scale through grouping?
• What are the specific tax incentives and disadvantages associated with transitioning to specific medical corporations or social medical corporations?

If You Feel “Should I Consult Too?”

If you are struggling to specifically grasp the impact of the 2026 fiscal year medical fee revision and how to incorporate it into your institution’s management strategy and business succession plan. In particular, managers concerned about measures against the risk of revenue reduction due to the revision, the possibility of collaboration/integration leveraging economies of scale, and organizational restructuring utilizing tax incentives should consider consulting with experts at this time.

M&A Medical (CentralMedience Co., Ltd.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultation here